<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
AGIO
Agios Pharmaceuticals
$
()


  • Royalty Pharma price target raised by $3 at Morgan Stanley, here's why

    7/11/2024 - 08:15am
  • JPMorgan biotech analysts hold an analyst/industry conference call

    6/17/2024 - 12:18pm
  • Agios Pharmaceuticals presents results from Phase 3 ENERGIZE study of mitapivat

    6/16/2024 - 07:11am
  • Intellia Therapeutics appoints Brian Goff to board of directors

    6/14/2024 - 07:33am
  • Agios Pharmaceuticals reinstated with a Neutral at JPMorgan

    6/13/2024 - 16:54pm
  • Agios Pharmaceuticals price target raised by $9 at RBC Capital, here's why

    6/3/2024 - 14:30pm
  • Agios reports Phase 3 ENERGIZE-T study of mitapivat met primary endpoint

    6/3/2024 - 06:41am
  • Biotech Alert: Searches spiking for these stocks today

    5/31/2024 - 10:44am
  • Biotech Alert: Searches spiking for these stocks today

    5/30/2024 - 11:04am
  • What You Missed On Wall Street This Morning

    5/28/2024 - 12:03pm
  • Agios investors paying nothing for Pyrukynd, says Cantor Fitzgerald

    5/28/2024 - 08:26am
  • Royalty Pharma, Agios enter into vorasidenib royalty agreement

    5/28/2024 - 07:15am
  • Agios Pharmaceuticals announces $905M purchase agreement for vorasidenib royalty

    5/28/2024 - 07:03am
  • Agios Pharmaceuticals expects cash to fund expenditures at least into 2026

    5/2/2024 - 07:05am
  • Agios Pharmaceuticals announces anticipated 2024 milestones

    5/2/2024 - 07:03am
dynamic_feed Breaking News